C-MER Ophthalmology was founded by renowned Hong Kong ophthalmologist Lam Shun Chiu, and after gaining a firm foothold in Hong Kong, it subsequently established the first Hong Kong-funded hospital in mainland China under the CEPA framework in Shenzhen, which has long been ranked among the top in the Shenzhen Medical and Health Public Satisfaction Survey. As a private ophthalmology hospital, C-MER Ophthalmology has established its advantages over public hospitals in terms of medical team, surgical standards, and patient experience, and has gradually made a name for itself among private ophthalmic medical institutions in China by relying on high-quality services. On January 15, 2018, C-MER Ophthalmology was listed on the Hong Kong Stock Exchange, attracting investment from Pony Ma.
At the end of 17 years, C-MER Beijing was the first wholly-owned ophthalmology hospital in Hong Kong approved by the Beijing Health and Family Planning Commission, and followed the "appointment appointment" model of C-MER Ophthalmology: after completing the doctor's appointment, the patient went to the hospital to receive five basic optometric examinations (including intraocular pressure, corneal thickness, visual acuity, etc.), and then the doctor consulted the patient, and then conducted a special eye examination according to the condition. For ophthalmology patients, this mode of consultation can better allow doctors to grasp the patient's condition and formulate a treatment plan, while avoiding repeated examinations and improving efficiency.
As the founder of C-MER Ophthalmology, Professor Lin Shunchao has a convincing resume as an ophthalmologist: he has obtained degrees from the University of Hong Kong Chinese, the Royal College of Ophthalmologists and the International Academy of Ophthalmologists, and has served as the director of the Department of Ophthalmology and Visual Sciences of the University of Hong Kong Chinese for many years, and is also the former director of the National Key Laboratory of Ophthalmology of Sun Yat-sen University. Patients can make an appointment with Professor Lin for a consultation at C-MA in Beijing, but they may have to wait for a while as they are not always in Beijing. In addition to Lin Shunchao, C-MER has also hired a team of local physicians with profound clinical experience in ophthalmology, especially Professor Zhang Feng, the chief ophthalmology expert of Beijing Tongren Hospital, and Yuan Junyan, a famous ophthalmologist from Beijing Shijitan Hospital, who have joined C-MER Beijing to join C-MER, which has greatly enhanced the influence of C-MER in the industry and society in Beijing.
At present, C-MER Ophthalmology has 9 specialties, including macular disease, laser vision correction and vitreoretinal, among which cataract, glaucoma and pediatric ophthalmology are the key departments, and the team of physicians has rich experience in clinical and scientific research in the corresponding fields. In addition, Frank Martin, an international doctor specializing in strabismus and amblyopia at C-MER Beijing, is currently the president of the Asia-Pacific Society of Strabismus and Pediatric Ophthalmology and the International Association of Strabismus, and has an authoritative position in the diagnosis, treatment and research of pediatric and adult strabismus.
Because Beijing does not allow applications for private medical institutions within the Fifth Ring Road, Beijing C-MER is located in Building 2 of the Rosewood Building in Gaobeidian, about a ten-minute walk from the subway station. In addition, because basic optometry is required before the face-to-face consultation, the time for patients to make an appointment through customer service is the time of arrival at the hospital, not the time of consultation, but both the doctor's attitude and the degree of meticulousness of diagnosis are much higher than those of public hospitals.
